BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$2.47B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.89B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$708M |
| 4 |
Industrial Select Sector SPDR Fund
XLI
|
+$524M |
| 5 |
Nike
NKE
|
+$468M |
Top Sells
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$301M |
| 2 |
Health Care Select Sector SPDR Fund
XLV
|
+$293M |
| 3 |
SPDR S&P Retail ETF
XRT
|
+$148M |
| 4 |
NVIDIA
NVDA
|
+$74.9M |
| 5 |
Technology Select Sector SPDR Fund
XLK
|
+$72.9M |
Sector Composition
| 1 | Technology | 17.94% |
| 2 | Consumer Discretionary | 10.22% |
| 3 | Financials | 8.36% |
| 4 | Healthcare | 7.6% |
| 5 | Industrials | 5.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Pure Cycle
PCYO
$276M
| $33.9K | ﹤0.01% |
2,817
-3,237
| -53% | -$38.9K |
|
2877
Clearside Biomedical
CLSD
$26.3M
| $33.5K | ﹤0.01% |
14,623
| – | – |
|
|
SPNE
2878
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $33.4K | ﹤0.01% |
2,748
-5,983
| -69% | -$72.8K |
|
|
XXII
2879
22nd Century Group
XXII
$6.39M
| – | – |
0
| – | -$198K |
|
|
CMRX
2880
DELISTED
Chimerix, Inc.
CMRX
| $33.3K | ﹤0.01% |
7,273
-9,995
| -58% | -$45.8K |
|
2881
iShares Core S&P Mid-Cap ETF
IJH
$101B
| $33.3K | ﹤0.01% |
620
-8,205
| -93% | -$440K |
|
2882
Aldeyra Therapeutics
ALDX
$343M
| $33.2K | ﹤0.01% |
7,468
-2,468
| -25% | -$11K |
|
2883
Superior Group of Companies
SGC
$193M
| $33.2K | ﹤0.01% |
1,858
-2,778
| -60% | -$49.6K |
|
|
AC
2884
DELISTED
Associated Capital Group
AC
| $33.1K | ﹤0.01% |
790
-960
| -55% | -$40.2K |
|
|
LUNA
2885
DELISTED
Luna Innovations Incorporated
LUNA
| $33.1K | ﹤0.01% |
4,287
-8,145
| -66% | -$62.8K |
|
2886
Atlanticus Holdings
ATLC
$1.03B
| $33K | ﹤0.01% |
638
-1,485
| -70% | -$76.9K |
|
2887
Evolus
EOLS
$470M
| $32.9K | ﹤0.01% |
2,932
-3,900
| -57% | -$43.8K |
|
2888
Perion Network
PERI
$418M
| $32.7K | ﹤0.01% |
1,455
-3,008
| -67% | -$67.7K |
|
2889
Puma Biotechnology
PBYI
$233M
| $32.7K | ﹤0.01% |
11,337
-17
| -0.1% | -$49 |
|
2890
Precision BioSciences
DTIL
$58.5M
| $32.6K | ﹤0.01% |
353
-157
| -31% | -$14.5K |
|
2891
Fomento Económico Mexicano
FMX
$30.9B
| $32.6K | ﹤0.01% |
393
+63
| +19% | +$5.22K |
|
2892
Honda
HMC
$44.4B
| $32.5K | ﹤0.01% |
1,150
-15,596
| -93% | -$441K |
|
2893
Global X Cloud Computing ETF
CLOU
$310M
| $32.3K | ﹤0.01% |
+1,471
| New | +$32.3K |
|
2894
Consumer Portfolio Services
CPSS
$189M
| $32.3K | ﹤0.01% |
3,181
+629
| +25% | +$6.39K |
|
|
ONCT
2895
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $31.4K | ﹤0.01% |
1,128
-591
| -34% | -$16.4K |
|
2896
Soleno Therapeutics
SLNO
$3.21B
| $31.2K | ﹤0.01% |
9,335
-11
| -0.1% | -$37 |
|
2897
Fidelity D&D Bancorp
FDBC
$260M
| $31.2K | ﹤0.01% |
672
-800
| -54% | -$37.1K |
|
2898
Allient
ALNT
$788M
| $31.2K | ﹤0.01% |
1,044
-2,524
| -71% | -$75.3K |
|
|
CBAY
2899
DELISTED
Cymabay Therapeutics
CBAY
| $31.1K | ﹤0.01% |
9,996
-114,803
| -92% | -$357K |
|
2900
Scholar Rock
SRRK
$3.04B
| $31K | ﹤0.01% |
2,405
-3,475
| -59% | -$44.8K |
|